Successful unrelated umbilical cord blood transplantation for class 3 β‐thalassemia major using a reduced‐toxicity regimen
Authors:
- 16 December 2013
- journal article
- case report
- Published by Wiley in Pediatric Transplantation
- Vol. 18 (2) , E41-E43
Abstract
Unrelated umbilical CB transplant for class 3 β‐thalassemia major is associated with an increased risk of mortality and non‐engraftment. We describe two patients who underwent successful unrelated umbilical CB transplant using a novel reduced‐toxicity preparative regimen. This regimen may be sufficiently immunosuppressive and myeloablative to ensure engraftment with reduced risks of toxicity and mortality. Close monitoring of HHV‐6 viral load is advised for patients undergoing transplant with this regimen.Keywords
This publication has 11 references indexed in Scilit:
- Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell DiseaseTransplantation and Cellular Therapy, 2011
- Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patientsBone Marrow Transplantation, 2011
- Advances in the allogeneic transplantation for thalassemiaBlood Reviews, 2008
- Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patientsAmerican Journal of Hematology, 2007
- Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipientsBlood, 2006
- Unrelated Bone Marrow Transplantation for β‐Thalassemia Patients: The Experience of the Italian Bone Marrow Transplant GroupAnnals of the New York Academy of Sciences, 2005
- Stem cell transplantation for thalassaemiaReproductive BioMedicine Online, 2005
- Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulinBone Marrow Transplantation, 2004
- Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemiaTransplantation and Cellular Therapy, 2003
- Marrow transplantation for patients with thalassemia: results in class 3 patientsBlood, 1996